These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 858916

  • 1. Effect of concanavalin A on the classical complement pathway.
    Langone JJ, Boyle MD, Borsos T.
    J Immunol; 1977 May; 118(5):1622-5. PubMed ID: 858916
    [Abstract] [Full Text] [Related]

  • 2. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
    Boyle MD, Langone JJ, Ohanian SH, Borsos T.
    J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
    [Abstract] [Full Text] [Related]

  • 3. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 4. Enhancing effect of concanavalin A on the hemolytic activity of anti-Forssman IgG: the role of C1.
    Langone JJ, Sandor M, Ejzemberg R.
    J Immunol; 1982 Sep; 129(3):1159-64. PubMed ID: 7108204
    [Abstract] [Full Text] [Related]

  • 5. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E, Platt JL, Howell DN, Marsh HC, Frank MM.
    J Immunol; 1999 Sep 15; 163(6):3549-58. PubMed ID: 10477630
    [Abstract] [Full Text] [Related]

  • 6. Complement-mediated hemolytic activity of succinylated concanavalin A: preparation and activity of cell intermediates.
    Langone JJ, Ejzemberg R.
    J Immunol; 1985 Feb 15; 134(2):1110-4. PubMed ID: 3965569
    [Abstract] [Full Text] [Related]

  • 7. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C, Zhang XH, Zhang Y, Lint TF, Gewurz H.
    J Immunol; 1998 Mar 15; 160(6):3006-13. PubMed ID: 9510205
    [Abstract] [Full Text] [Related]

  • 8. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
    Loos M, Thesen R.
    J Immunol; 1978 Jul 15; 121(1):24-8. PubMed ID: 670702
    [Abstract] [Full Text] [Related]

  • 9. EAC4 and EAC14 production without purified Ci.
    Linscott WD.
    J Immunol; 1975 Dec 15; 115(6):1625-30. PubMed ID: 241767
    [Abstract] [Full Text] [Related]

  • 10. Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement.
    Knutzen Steuer KL, Sloan LB, Oglesby TJ, Farries TC, Nickells MW, Densen P, Harley JB, Atkinson JP.
    J Immunol; 1989 Oct 01; 143(7):2256-61. PubMed ID: 2506280
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI, Ohanian SH, Borsos T.
    Cancer Res; 1976 Oct 01; 36(10):3672-7. PubMed ID: 182362
    [Abstract] [Full Text] [Related]

  • 12. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
    Ji YH, Matsushita M, Okada H, Fujita T, Kawakami M.
    J Immunol; 1988 Dec 15; 141(12):4271-5. PubMed ID: 3058802
    [Abstract] [Full Text] [Related]

  • 13. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ, Hoffmann EM.
    J Immunol; 1984 Sep 15; 133(3):1444-52. PubMed ID: 6430999
    [Abstract] [Full Text] [Related]

  • 14. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
    Ejzemberg R, Borsos T.
    J Immunol; 1982 Apr 15; 128(4):1600-2. PubMed ID: 7061844
    [Abstract] [Full Text] [Related]

  • 15. Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG.
    Langone JJ, Boyle MD, Borsos T.
    J Immunol; 1978 Jul 15; 121(1):327-32. PubMed ID: 353195
    [Abstract] [Full Text] [Related]

  • 16. Complement inhibitor(s) released by leukocytes. I. Pretreatment of sheep erythrocytes with supernatants of mouse spleen and thymus cells inhibit whole complement activity and C2 utilization.
    Bernard A, Boumsell L, Borsos T, Good RA, Day NK.
    J Immunol; 1975 Oct 15; 115(4):1087-90. PubMed ID: 1176766
    [Abstract] [Full Text] [Related]

  • 17. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI, Jenkins DE, Leddy JP.
    J Immunol; 1985 Jan 15; 134(1):506-11. PubMed ID: 3964820
    [Abstract] [Full Text] [Related]

  • 18. Immunochemical quantitaion of the third component of guinea pig complement in fluid phase and bound to cell surfaces.
    Ohanian SH, Borsos T.
    J Immunol; 1975 Jan 15; 114(1 Pt 2):326-30. PubMed ID: 1167878
    [Abstract] [Full Text] [Related]

  • 19. A new haemolytic assay for the second component of complement (C2) in human serum.
    Naish PF, Barratt J, Collins C.
    Clin Exp Immunol; 1976 Sep 15; 25(3):487-9. PubMed ID: 963910
    [Abstract] [Full Text] [Related]

  • 20. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H, Tsuboi M, Nagaki K.
    Immunology; 1986 Jul 15; 58(3):459-65. PubMed ID: 3733147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.